011040 — Kyungdong Pharm Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Kyungdong Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	176,500	173,828	177,611	182,718	162,674
Cost of Revenue
Gross Profit	103,569	98,608	97,170	94,994	88,306
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	139,194	154,877	161,855	174,906	187,347
Operating Profit	37,306	18,950	15,755	7,812	-24,673
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	34,944	19,339	18,432	17,941	-18,503
Provision for Income Taxes
Net Income After Taxes	22,831	12,873	12,627	12,113	-20,730
Minority Interest
Net Income Before Extraordinary Items
Net Income	20,126	12,459	12,672	12,161	-20,708
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	20,126	12,459	12,672	12,161	-20,708
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	498	507	459	463	-771
Dividends per Share